Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
66
Views
10
CrossRef citations to date
0
Altmetric
Original Research

RETRACTED ARTICLE: LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis

Yu Li1 Department of Oncology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, 150040, People’s Republic of China
,
Liqin Wang2 Nursing Teaching and Research Department, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, 150040, People’s Republic of China
,
Xiaoyi Xu3 Department of Medical Laboratory, First Clinical Medical College, Mudanjiang Medical University, Mudanjiang City, Heilongjiang Province, 157011, People’s Republic of China
,
Heng Sun1 Department of Oncology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, 150040, People’s Republic of China
&
Leilei Wu4 Pharmacy Laboratory, College of Pharmacy, Mudanjiang Medical University, Mudanjiang City, Heilongjiang Province, 157011, People’s Republic of ChinaCorrespondence[email protected]
Pages 7543-7557 | Published online: 01 Oct 2021

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yufen Xu, Xiaoli Tan, Qi Yang, Zhixian Fang & Wenyu Chen. (2024) LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis. Expert Review of Anticancer Therapy 24:1-2, pages 81-93.
Read now
Shataer Aini, Shayiti Bolati, Wei Ding, Siyin Liu, Pengcheng Su, Saiding Aili, Yimin Naman & Kuerban Xuekelaiti. (2022) LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer. Bioengineered 13:5, pages 11430-11439.
Read now

Articles from other publishers (8)

L. Zheng, A. Chopra, J. Weiner3rd3rd, D. Beule, H. Dommisch & A. S. Schaefer. (2023) miRNAs from Inflamed Gingiva Link Gene Signaling to Increased MET Expression. Journal of Dental Research 102:13, pages 1488-1497.
Crossref
Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib, Rahman S. Zabibah, Qakhramon Shomurodov, Mostafai N. Kadheim, Fahad Alsaikhan, Pushpamala Ramaiah, Lathamangeswari Chinnasamy & Saeed Samarghandian. (2023) A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer. Biomedicine & Pharmacotherapy 166, pages 115337.
Crossref
Weixi Chen, Zekun Bai, Wen Bai, Wei Wang, Jiapei Guo, Mengnan Guo, Yingying Sai, Jun Shi & Jinghua Wu. (2023) LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway. Scientific Reports 13:1.
Crossref
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, Wen Fu, Wen Sun, Qiancheng Ma, Dongsheng Huang & Qiuran Xu. (2023) Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review). Oncology Reports 49:3.
Crossref
Xuemei Zeng, Juan Xiao, Xue Bai, Yiwen Liu, Meilan Zhang, Jiangrong Liu, Zixuan Lin & Zhiwei Zhang. (2022) Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer. Pathology - Research and Practice 238, pages 154030.
Crossref
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, Nadine De Godoy Torso, Marília Berlofa Visacri, Patricia Moriel & Luis A. Salazar. (2022) Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. Frontiers in Pharmacology 13.
Crossref
Xiang Xu, Yeqing Tang, Jiashan Zhu & Jinhua Luo. (2022) Endoplasmic Reticulum Stress-Related Four-Biomarker Risk Classifier for Survival Evaluation in Esophageal Cancer. Journal of Oncology 2022, pages 1-14.
Crossref
Ying Liu, Xiang Ao, Yu Wang, Xiaoge Li & Jianxun Wang. (2022) Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance. Frontiers in Oncology 12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.